![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Feedback Plc | LSE:FDBK | London | Ordinary Share | GB00BJN59X09 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
7.50 | 11.11% | 75.00 | 73.00 | 77.00 | 78.50 | 67.50 | 67.50 | 53,502 | 16:17:50 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Computers | 1.03M | -2.92M | -0.2188 | -3.43 | 10M |
Date | Subject | Author | Discuss |
---|---|---|---|
10/11/2021 14:26 | I see they're working on the Feedback site now. | ![]() ged5 | |
10/11/2021 14:08 | Yes that part is much better. | ![]() yump | |
10/11/2021 14:05 | It takes time but I am now beginning to see the benefits. Those of us who regularly visit the website have seen great improvements over the past few months. I wasn't sure who was the targeted audience before the changes. It was slowly evolving towards a customer audience. The Feedback site is obviously the main one for investors. | ![]() ged5 | |
10/11/2021 13:41 | Haha, they've got to catch me first. Not sure what to make of that, LR2. I presume it's a service they pay for. At least they're top of the list with Nissan. | ![]() ged5 | |
10/11/2021 13:22 | Studiomade working with Feedback. | ![]() lr2 | |
10/11/2021 13:11 | Thing is Ged I am not sure Tom is looking at the prison system just yet ;-) | ![]() ragnarr | |
10/11/2021 11:17 | Had an X-ray this morning that I've been waiting nine weeks for and took the opportunity to ask the radiographers to look at Bleepa.com. They seemed very keen to do so when I was talking about Bleepa. | ![]() ged5 | |
10/11/2021 10:41 | It turned up after hours yesterday but bore an 8/11 timestamp. 08-Nov-21 12:27:59 1.05p 3,300,000 | ![]() lr2 | |
10/11/2021 10:01 | When was the 3.3 million buy? | ![]() herb clark | |
10/11/2021 09:44 | Very quiet today - needs some more RNS’d pilots or contracts to get properly noticed I think. That rise is probably just podcast followers. | ![]() yump | |
09/11/2021 18:30 | That 3.3m buy is an indication that Feedback is being taken seriously. Thanks for pointing it out Ged as I'd missed it. | ![]() lr2 | |
09/11/2021 18:13 | Nice 3.3m buy from yesterday reported after hours. Good volume again today. Now wouldn't it be a good time to make an announcement. Let's say a RNS rather than some obscure platform. So refreshing to see the desire for traditional process. | ![]() ged5 | |
09/11/2021 13:37 | Well maybe its just because he’s new to running a commercial business and its also a PLC. You’d expect his advisors might have been a little more on the ball though, especially given that the dilution would not have been so high at a higher issue price. Maybe the continuous drop after 1p was because there was chatter about a placing, but with none of the info in that podcast - so an inevitable drop. | ![]() yump | |
09/11/2021 13:14 | As a shareholder I'm happy to see the price go up but I feel uneasy about the process. Are we to believe that 57% of the market cap has been raised based on no more information than is contained in the 2nd Nov RNS? i.e. those who took up the conditional Placing were not in possession of some of the information given in the SundayRoast podcast? It is so unusual in my experience (though AIM never ceases to surprise). Capital raises on AIM are usually limited to 50%, discounts are below 10% and a prospectus is issued. None apply to this conditional placing and open offer. And it still puzzles me why TO used such an obscure platform to announce his news. And why not issue the news before the raise, thus reducing the discount. Questions, questions... | ![]() ptolemy | |
09/11/2021 12:58 | I'll put these links in the header for easy reference. Things get lost in a thread. I'll also put the first post of the interview that Ragnarr so kindly transcribed for us so we'll have ready reference to post number. Edit: I've put the whole transcript in a scroll box | ![]() ged5 | |
09/11/2021 12:06 | Its poor isnt it and it seems that everyone just seems to accept that this is how the NHS works. Its such a wonderful institution but could be soooo much better.I could be wrong but I get the feeling that Covid is starting to change the inward looking complacency that is holding it back. | ![]() ragnarr | |
09/11/2021 11:35 | “Guidance published in 2011” 10 years later some still don’t get near the recommendations. That’s shocking. I bet nobody has been fired though. | ![]() yump | |
09/11/2021 10:14 | NHS GIRFT Programme National Specialty Report 2020https://www.gett | ![]() ragnarr | |
09/11/2021 09:50 | we think that this is one of the rare occasions where the NHS really should procure one solution for doing this, and. We are making that case, both centrally at a very senior level, but also regionally | ![]() ragnarr | |
09/11/2021 09:45 | Missed that ragnarr - thanks. Hopefully a few more trials will appear. Better than relying on cross-trust recommendations. When talking about roll-out, I imagine thats not centrally controlled by the NHS, so it will need individual local sales effort. | ![]() yump | |
09/11/2021 09:43 | Correct Ged | ![]() ducatiman | |
09/11/2021 09:41 | I see there's been some profit taking this morning but I think: | ![]() ged5 | |
09/11/2021 09:34 | From the interview..having just announced the funding I spent the last four days travelling all around erm. for various site visits within the UK to get the ..erm. the ICS ..erm and CDC opportunities moving | ![]() ragnarr | |
09/11/2021 09:19 | My 570k buy not showing | ![]() herb clark |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions